Priscila G. Camargo

Londrina, PR, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Integrative in silico and in vitro discovery of a novel thiazolidinone derivative as arginase inhibitor with potent antileishmanial activity.

Integrative in silico and in vitro discovery of a novel thiazolidinone derivative as arginase inhibitor with potent antileishmanial activity.

Journal: Chemico-biological interactions

Published: March 30, 2026

Integrated in silico and in vitro approaches reveal novel coumarin hybrids targeting influenza A virus RNA-dependent RNA polymerase.

Integrated in silico and in vitro approaches reveal novel coumarin hybrids targeting influenza A virus RNA-dependent RNA polymerase.

Journal: European journal of medicinal chemistry

Published: December 12, 2025

Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study.

Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study.

Journal: Scientific reports

Published: August 26, 2025

Inhibitory activity of amino acid derivatives against native Cryptococcus neoformans urease and ligand-enzyme binding profile by nuclear Paramagnetic Relaxation Enhancement and Saturation Transfer Difference NMR.

Inhibitory activity of amino acid derivatives against native Cryptococcus neoformans urease and ligand-enzyme binding profile by nuclear Paramagnetic Relaxation Enhancement and Saturation Transfer Difference NMR.

Journal: Bioorganic chemistry

Published: June 17, 2025

Integrated chemical and genomic analysis of lipopeptides produced by Bacillus velezensis CMRP4489 with antifungal activity.

Integrated chemical and genomic analysis of lipopeptides produced by Bacillus velezensis CMRP4489 with antifungal activity.

Journal: Scientific reports

Published: January 24, 2025

Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies.

Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies.

Journal: Scientific reports

Published: November 01, 2024

In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition.

In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition.

Journal: Scientific reports

Published: August 27, 2024

In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations.

In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations.

Journal: Scientific reports

Published: August 27, 2024

Effect of a thiohydantoin salt derived from l-Arginine on Leishmania amazonensis and infected cells: Insights from biological effects to molecular docking interactions.

Effect of a thiohydantoin salt derived from l-Arginine on Leishmania amazonensis and infected cells: Insights from biological effects to molecular docking interactions.

Journal: Chemico-biological interactions

Published: February 27, 2024

Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.

Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.

Journal: Scientific reports

Published: February 07, 2024

Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro.

Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro.

Journal: Scientific reports

Published: December 28, 2023

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro).

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro).

Journal: Scientific reports

Published: October 26, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026